FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical composition for treating diabetes, obesity or metabolic syndrome, which includes therapeutically efficient amount of (5-hydroxyadamantan-2-yl)amide of trans-2'-tret-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid or its pharmaceutically acceptable salts, and pharmaceutically acceptable carrier.
EFFECT: invention also relates to application of said compound for preparation of medication, intended for treatment of said diseases.
2 cl, 1 tbl, 99 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLES AS 11-BETA-HSD-1 INHIBITORS | 2007 |
|
RU2402517C2 |
| 11β-HYDROXYSTEROID DIHYDROGENASE INHIBITORS | 2008 |
|
RU2440989C2 |
| PYRAZOLE DERIVATIVES AS 11-BETA-HSD1 INHIBITORS | 2008 |
|
RU2462456C2 |
| D-TAGATOSE COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ATHEROSCLEROSIS, METABOLIC SYNDROME AND SYMPTOMS THEREOF | 2009 |
|
RU2484827C2 |
| SUBSTITUTED 3-CYANOTIOPHENACETAMIDES AS GLUCAGON RECEPTOR ANTAGONISTS | 2004 |
|
RU2336274C2 |
| PYRIDINCARBOXAMIDES AS 11-BETA-HSD1 INHIBITORS | 2007 |
|
RU2451674C2 |
| METHODS, COMPOUNDS AND COMPOSITIONS FOR TREATING ANGIOTENSIN-ASSOCIATED DISEASES | 2014 |
|
RU2688163C2 |
| UREA GLUCOKINASE ACTIVATORS | 2006 |
|
RU2443691C2 |
| CYCLOALKYLAMINE DERIVATIVES | 2005 |
|
RU2402526C2 |
| 3,3-DISUBSTITUTED-(8-AZABICYCLO[3.2.1]OCTA-8-YL)-[5-(1H-PYRASOL-4-YL)-THIOPHEN-3-YL]- METHANONE AND RELATED COMPOUNDS AND THEIR USE | 2011 |
|
RU2593753C2 |
